ID: ALA2115099

Max Phase: Preclinical

Molecular Formula: C8H10ClN3O4

Molecular Weight: 247.64

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(=O)n([C@@H]2CO[C@@H](CO)O2)cc1Cl

Standard InChI:  InChI=1S/C8H10ClN3O4/c9-4-1-12(8(14)11-7(4)10)5-3-15-6(2-13)16-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1

Standard InChI Key:  FHQBEXAIBWHLBV-NTSWFWBYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 247.64Molecular Weight (Monoisotopic): 247.0360AlogP: -0.66#Rotatable Bonds: 2
Polar Surface Area: 99.60Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.85CX Basic pKa: CX LogP: -0.66CX LogD: -0.66
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.72Np Likeness Score: 0.37

References

1. Lee M, Chu CK, Balakrishna Pai S, Zhu Y, Cheng Y, Chun MW, Chung WK.  (1995)  Dioxolane cytosine nucleosides as anti-hepatitis B agents,  (17): [10.1016/0960-894X(95)00343-R]

Source